Open AccessThe Use of Non‐Immune Plasma Powder in the Prophylaxis of Neonatal Escherichia coli Diarrhoea in Calves
Author(s) -
Nollet H.,
Laevens H.,
Deprez P.,
Sanchez R.,
Driessche E. Van,
Muylle E.
Publication year - 1999
Publication title -
journal of veterinary medicine series a
Language(s) - English
Resource type - Journals
eISSN - 1439-0442
pISSN - 0931-184X
DOI - 10.1046/j.1439-0442.1999.00208.x
Subject(s) - colostrum , escherichia coli , excretion , diarrhea , microbiology and biotechnology , strain (injury) , feces , immune system , fimbria , biology , medicine , antibody , immunology , endocrinology , biochemistry , gene
The protective use of plasma powder from cattle and swine against experimentally induced neonatal E. coli diarrhoea in colostrum‐deprived calves was examined. Diarrhoea was induced with a strain expressing F5 + fimbriae and a strain expressing F17 + fimbriae. In all groups supplemented with bovine plasma powder, diarrhoea and fever were less severe than in the control groups. For the groups infected with the F5 + E. coli strain, a reduction in excretion of the challenge strain by 2–4 orders of magnitude and by 1–2 orders of magnitude was seen when supplemented with bovine plasma powder at a dose of 25 g/l milk and 10 g/l milk, respectively. The bovine plasma powder showed also beneficial effects in the F17 + infected groups. No mortality, no septicaemia and no severe clinical signs were observed. Concerning the excretion of the E. coli F17 + strain in the faeces, no significant difference with the control group was found. Swine plasma powder showed little beneficial effect on E. coli diarrhoea in calves in this study.